Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Ovid Therapeutics Inc. is a biopharmaceutical company focused on developing small molecule medicines for brain conditions with unmet needs, including epilepsy and psychosis. Its pipeline features innovative therapies targeting neuronal hyperexcitability, such as GABA-AT inhibitors, KCC2 activators, and ROCK2 inhibitors. The company aims to deliver safer, more effective treatments for neurological and psychiatric disorders, leveraging strategic licensing, collaborations, and a scientific approach to address fundamental brain biology.
This description was generated via AI from an annual report. Updated about 1 year ago.